Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Shijiazhuang, China Clinical Trials

A listing of Shijiazhuang, China clinical trials actively recruiting patients volunteers.


Found (3) clinical trials

CAR-T Immunotherapy Targeting CD19- ALL

Anti-CD19 chimeric antigen receptor T cell therapy has demonstrated unprecedented treatment responses in relapsing/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL). However, many studies have reported that a subset of patients still relapse and about 30-50% of those relapses are characterized by the loss of CD19 surface antigen. Patients with CD19-negative ...


0.0 miles

Learn More »

CAR T Cells for Refractory B Cell Malignancy

The CAR consists of a CD19 targeting antibody scFv with three intracellular signaling domains derived from CD3 zeta, CD28 and 4-1BB. Autologous T cells will be gene engineered with the CAR gene using a lentivirus vector. Prior to T cell infusion, the patients will be subjected to preconditioning treatment. After ...


1.34 miles

Learn More »

Gingiva Mesenchymal Stem Cells Treatment of Chronic Periodontitis

Periodontitis featured by the progressive destruction loss of support tissues around the teeth has become a prevalent disease affecting the life quality of the adults. Although conventional periodontal treatment including open flap debridement and drug support therapy display reduced pocket depth and inflammation, the functional regeneration of the lost tissue ...


2.52 miles

Learn More »